Average Co-Inventor Count = 7.06
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Aktiengesellschaft (13 from 1,384 patents)
2. Novartis Ag (5 from 3,923 patents)
3. Genzyme Corporation (3 from 789 patents)
4. Bayer Schering Pharma Ag (2 from 192 patents)
5. Other (1 from 832,843 patents)
6. Morphosys Ag (1 from 88 patents)
7. Eberhard-karls-universitat Tubingen (1 from 16 patents)
8. Schering Aktienegesellschaft (1 from 1 patent)
23 patents:
1. 11186638 - Anti-αβTCR antibody
2. 11142575 - Methods for enhancing immunosuppressive therapy by multiple administration of αβTCR-binding polypeptide
3. 10017573 - Anti-αβTCR antibody
4. 7785591 - Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
5. 7615565 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
6. 7517894 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
7. 7479491 - Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors
8. 7459470 - N-oxide anthranylamide derivatives and their use as medicaments
9. 7429592 - Cyanoanthranilamide derivatives and the use thereof as medicaments
10. 7335775 - Effector conjugates, process for their production and their pharmaceutical use
11. 7202260 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
12. 7148357 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
13. 7129254 - Effector conjugates, process for their production and their pharmaceutical use
14. 7122547 - Anthranilic acid amides and the use thereof as medicaments
15. 7081468 - Ortho-substituted anthranilic acid amides and their use as medicaments